Announcing Illuminant’s $8.4M Seed Round

gravatar
 | 
April 30, 2026
 | 
1 min read
Featured Image

Illuminant Surgical is excited to announce our $8.4M Series Seed, featured in Fortune by Allie Garfinkle.

With this funding, our team has already been able to accelerate our engineering, manufacturing, and clinical efforts. We’ve recently opened the doors to our new 12,000 sq ft headquarters in Los Angeles. By housing our R&D labs, pilot manufacturing lines, and dedicated BSL-2 cadaver lab all under one roof, we’ve drastically reduced time from clinical insight to product.

We’re excited to roll-out our first production-equivalent Skylight systems from our manufacturing line in the next few weeks.

Our mission is simple: we want doctors to never miss.

Thank you to our incredible team, our clinical partners, and our investors for backing this vision.

Read the full feature in Fortune here.

Read the press release here.

Comments

No Comments.

logo_footer_high

2440 S Sepulveda Blvd
Ste 125
Los Angeles, CA 90064

The information presented on this website reflects the current development stage and intended capabilities of the Skylight Surgical Navigation System. Skylight has not been approved or cleared by the U.S. Food and Drug Administration (FDA) and is not available for sale or commercial use. No claims are made regarding the device’s safety or effectiveness.